SEC Form 4 · accession 0001144204-15-021908
CV Sciences, Inc. · CVSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph D Dowling
Officer — Chief Financial Officer
Period of report
Oct 1, 2014
Accepted (ET)
Apr 8, 2015 · 9:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510964
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.82 | Oct 1, 2014 | A | 600,000 | A | — | Sep 30, 2024 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F1The option is durational-based, and vests and becomes exercisable as follows: (i) twenty-five percent (25%) of the shares subject to the option will be vested upon the one (1) year anniversary of the vesting commencement date; and (ii) the balance of the shares subject to the option will be vested in a series of thirty-six (36) successive equal monthly installments measured from the first annivesary of the vesting commencement date. The vesting commencement date for the option is June 16, 2014.